Trinity biotech announces ce mark of its covid-19 igg elisa antibody test

Dublin, ireland, jan. 05, 2021 (globe newswire) -- trinity biotech plc (nasdaq: trib) has achieved ce mark approval and registration for its covid-19 igg elisa antibody test, the captia™ sars-cov-2 igg elisa.
TRIB Ratings Summary
TRIB Quant Ranking